Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jeremy Mills,. (2021) Nurses Must Consider the Impact of Anticholinergic Medications in Schizophrenia Spectrum Disorders. Issues in Mental Health Nursing 42:9, pages 887-889.
Read now
Read now
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2020) Potentially inappropriate prescriptions of anticholinergic drugs in patients with benign prostatic hyperplasia. The Aging Male 23:5, pages 785-792.
Read now
Read now
Jay Khastgir. (2019) Antimuscarinic drug therapy for overactive bladder syndrome in the elderly – are the concerns justified?. Expert Opinion on Pharmacotherapy 20:7, pages 813-820.
Read now
Read now
Prasad S. Nishtala, Mohammed Saji Salahudeen & Sarah N. Hilmer. (2016) Anticholinergics: theoretical and clinical overview. Expert Opinion on Drug Safety 15:6, pages 753-768.
Read now
Read now
Gillian F Wolff, George A Kuchel & Phillip P Smith. (2014) Overactive bladder in the vulnerable elderly. Research and Reports in Urology 6, pages 131-138.
Read now
Read now
Gary G. Kay, Paul Maruff, David Scholfield, Bimal Malhotra, Laurence Whelan, Amanda Darekar & Diane L. Martire. (2012) Evaluation of Cognitive Function in Healthy Older Subjects Treated with Fesoterodine. Postgraduate Medicine 124:3, pages 7-15.
Read now
Read now
Articles from other publishers (109)
Yuki Okita, Tetsuhisa Kitamura, Sho Komukai, Ling Zha, Masayo Komatsu, Nobuhiro Narii, Fumiko Murata, Maeda Megumi, Yasufumi Gon, Yasuyoshi Kimura, Kosuke Kiyohara, Tomotaka Sobue & Haruhisa Fukuda. (2023) Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study. International Journal of Geriatric Psychiatry 38:12.
Crossref
Crossref
Bilal Katipoglu, Seda Kurtbeyoglu, Zeliha Asli Demir & Hayrettin Levent Mavioglu. (2023) The effect of the anticholinergic burden on mortality following elective cardiac surgery. Current Medical Research and Opinion, pages 1-20.
Crossref
Crossref
Danielle S. Abraham, Thanh Phuong Pham Nguyen, Craig W. Newcomb, Shelly L. Gray, Sean Hennessy, Charles E. Leonard, Qing Liu, Daniel Weintraub & Allison W. Willis. (2023) Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease. Parkinsonism & Related Disorders 115, pages 105822.
Crossref
Crossref
Amani M. Norling, Aleena Bennett, Michael Crowe, D. Leann Long, Sara A. Nolin, Terina Myers, Victor A. Del Bene, Ronald M. Lazar & Adam Gerstenecker. (2023) Longitudinal associations of anticholinergic medications on cognition and possible mitigating role of physical activity. Journal of the American Geriatrics Society 71:6, pages 1937-1943.
Crossref
Crossref
Yajie Jiang, Manshu Zou, Yeqing Wang & Yuhong Wang. (2023) Nucleus accumbens in the pathogenesis of major depressive disorder: A brief review. Brain Research Bulletin 196, pages 68-75.
Crossref
Crossref
Mariona Espaulella-Ferrer, Nuria Molist-Brunet, Joan Espaulella-Panicot, Daniel Sevilla-Sánchez, Emma Puigoriol-Juvanteny & Marta Otero-Viñas. (2023) Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study. International Journal of Environmental Research and Public Health 20:7, pages 5322.
Crossref
Crossref
Zeynep Katipoğlu & Rafiye Nur Abay. (2023) The relationship between dry eye disease and anticholinergic burden. Eye.
Crossref
Crossref
Jie Xu, Hao Zhang, Hansi Zhang, Jiang Bian & Fei Wang. (2023) Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design. Scientific Reports 13:1.
Crossref
Crossref
. 2023. An Insider's Perspective of Prostate Cancer. An Insider's Perspective of Prostate Cancer
113
141
.
Lenka Pulkrabkova, Barbora Svobodova, Jan Konecny, Tereza Kobrlova, Lubica Muckova, Jiri Janousek, Jaroslav Pejchal, Jan Korabecny & Ondrej Soukup. (2022) Neurotoxicity evoked by organophosphates and available countermeasures. Archives of Toxicology 97:1, pages 39-72.
Crossref
Crossref
Christine Salahub, Peter E. Wu, Lisa D. Burry, Christine Soong, Kathleen A. Sheehan, Thomas E. MacMillan & Lauren Lapointe-Shaw. (2022) Melatonin for Insomnia in Medical Inpatients: A Narrative Review. Journal of Clinical Medicine 12:1, pages 256.
Crossref
Crossref
Theodore M. JohnsonIIII, David Walker, Amy Lockefeer, Baoguo Jiang, David Nimke, Greta Lozano‐Ortega & Tomomi Kimura. (2022) Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population. Neurourology and Urodynamics 41:8, pages 1872-1889.
Crossref
Crossref
Michaela Mayerová & Libor Ustohal. (2022) Some of the less frequent side effects of antipsychotics. Psychiatrie pro praxi 23:3, pages 144-149.
Crossref
Crossref
Annabelle Hook, Jessica L. Randall, Carla M. Grubb, Natalie Ellis, Jack Wellington, Aayushi Hemmad, Agisilaos Zerdelis, Andrew R. D. Winnett, Benjamin D. W. Geers, Bethany Sykes, Charlotte N. Auty, Cecilia Vinchenzo, Christiane E. Thorburn, Daniella Asogbon, Emily Granger, Heather Boagey, Juliet Raphael, Kajal Patel, Kartik Bhargava, Mary-Kate M. Dolley, Matthew J. Maden, Mehdin M. Shah, Qao M. Lee, Ratnaraj Vaidya, Simran Sehdev, Sneha Barai, Sophie Roche, Uzair Khalid, David A. Codling & Judith R. Harrison. (2022) Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study. BMC Geriatrics 22:1.
Crossref
Crossref
Susmita Chandramouleeshwaran, Zaid Ghazala, José N Nobrega, Roger Raymond, Sara Gambino, Bruce G. Pollock & Tarek K Rajji. (2022) Cell-based serum anticholinergic activity assay and working memory in cognitively healthy older adults before and after scopolamine: An exploratory study. Journal of Psychopharmacology 36:9, pages 1070-1076.
Crossref
Crossref
Kanchan Dongre, Anja Jungo, Selina Späni, Yvonne Zysset & Anne Leuppi-Taegtmeyer. (2022) Disease-Drug Interactions Requiring Special Attention. Praxis 111:12, pages 700-705.
Crossref
Crossref
M E Friedrich, R Grohmann, U Rabl, D Winkler, A Konstantinidis, R Engel, J Seifert, S Toto, S Stübner, R Frey & S Kasper. (2022) Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016. International Journal of Neuropsychopharmacology 25:7, pages 556-566.
Crossref
Crossref
Prasad S. Nishtala & Te-yuan Chyou. (2022) An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019. Drugs & Aging 39:8, pages 657-669.
Crossref
Crossref
Alexander Sydat Bang, Maurice Marcel GarciaKieron Seymour LeslieErin Huiras Amerson. (2022) Management of Neovaginal Secretions After Salvage Gender Affirming Right-Colon Vaginoplasty Using Glycopyrrolate. Transgender Health.
Crossref
Crossref
Guillem Navarra-Ventura, Muriel Vicent-Gil, Maria Serra-Blasco, Jesús Cobo, Sol Fernández-Gonzalo, Ximena Goldberg, Mercè Jodar, Josep Maria Crosas, Diego Palao, Guillermo Lahera, Eduard Vieta & Narcís Cardoner. (2021) Higher order theory of mind in patients with bipolar disorder and schizophrenia/schizoaffective disorder. European Archives of Psychiatry and Clinical Neuroscience 272:3, pages 497-507.
Crossref
Crossref
Stefania Chiappini, Alessio Mosca, Andrea Miuli, Francesco Maria Semeraro, Gianluca Mancusi, Maria Chiara Santovito, Francesco Di Carlo, Mauro Pettorruso, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano & Massimo Di Giannantonio. (2022) Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines 10:2, pages 355.
Crossref
Crossref
Rand Hussein, Zhoushanyue He, Julia Bareham, Tejal Patel, Rosemary Killeen & Kelly Grindrod. (2022) Evaluating the Effectiveness of the Computer-Based Education Platform, Pharmacy5in5, on Pharmacists’ Knowledge of Anticholinergic Toxicity Using a Randomized Controlled Trial. Pharmacy 10:1, pages 8.
Crossref
Crossref
Karen Mate, Karen Kerr, Alison Priestley, Natasha Weaver, Gerald A. Broe, Gail Daylight, Brian Draper, Robert Cumming, Hemi Robinson-Kingi, Kim Delbaere & Kylie Radford. (2020) Use of tricyclic antidepressants and other anticholinergic medicines by older Aboriginal Australians: association with negative health outcomes. International Psychogeriatrics 34:1, pages 71-78.
Crossref
Crossref
Colin M. Smith, Paul B. Hicks, Jon K. Lindefjeld, Benjamin M. Taylor, Daniel R. Fisher, John J. Faragon, Sherrell T. Lam, Luis F. Pereira & Kelly L. Cozza. 2022. HIV Psychiatry. HIV Psychiatry
415
476
.
José N. Nobrega, Roger Raymond, Tarek K. Rajji & Bruce G. Pollock. (2021) A calcium fluorescence assay for quantification of cholinergic receptor activity of clinical drugs in serum - comparison with radioactive methods. Journal of Pharmacological and Toxicological Methods 112, pages 107118.
Crossref
Crossref
Krzysztof Wilczyński, Marta Gorczyca, Jagna Gołębiowska & Jan Szewieczek. (2021) Anticholinergic Burden of Geriatric Ward Inpatients. Medicina 57:10, pages 1115.
Crossref
Crossref
Sina Marzoughi, Ankur Banerjee, Catherine R. Jutzeler, Marco A.M. Prado, Jan Rosner, Jacquelyn J. Cragg & Neil Cashman. (2021) Tardive neurotoxicity of anticholinergic drugs: A review. Journal of Neurochemistry 158:6, pages 1334-1344.
Crossref
Crossref
Yong-Bo Zheng, Le Shi, Xi-Mei Zhu, Yan-Ping Bao, Li-Juan Bai, Jin-Qiao Li, Jia-Jia Liu, Ying Han, Jie Shi & Lin Lu. (2021) Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 127, pages 296-306.
Crossref
Crossref
Sergio J. Ruiz, Victor Cevallos, Dhanya Baskaran, Michael J. Mintzer & Jorge G. Ruiz. (2020) The cross-sectional association of frailty with past and current exposure to strong anticholinergic drugs. Aging Clinical and Experimental Research 33:8, pages 2283-2289.
Crossref
Crossref
Charisse Chehovich. (2021) Irreversible effects of anticholinergic withdrawal in the elderly: a case report. Aging Pathobiology and Therapeutics 3:2, pages 28-31.
Crossref
Crossref
Yewon Suh, Young-Mi Ah, Eunsook Lee & Ju-Yeun Lee. (2020) Association of inappropriate polypharmacy with emergency department visits in older patients receiving anti-neoplastic therapy: a population-based study. Supportive Care in Cancer 29:6, pages 3025-3034.
Crossref
Crossref
Satabdi Chatterjee, David Walker, Tomomi Kimura & Rajender R. Aparasu. (2021) Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder. Drugs & Aging.
Crossref
Crossref
Alessandro Cuomo, Angelo Bianchetti, Annachiara Cagnin, Domenico De Berardis, Ignazio Di Fazio, Raffaele Antonelli Incalzi, Camillo Marra, Francesca Neviani & Ferdinando Nicoletti. (2021) Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use. Journal of Gerontology and Geriatrics 69:2, pages 120-129.
Crossref
Crossref
Mark James Rawle, Laura McCue, Elizabeth L. Sampson, Daniel Davis & Victoria Vickerstaff. (2021) Anticholinergic Burden Does Not Influence Delirium Subtype or the Delirium–Mortality Association in Hospitalized Older Adults: Results from a Prospective Cohort Study. Drugs & Aging 38:3, pages 233-242.
Crossref
Crossref
Demetra Antimisiaris, Brittany McHolan, Daniela Moga & Cortney Mospan. (2021) Medication Related Problems. The Senior Care Pharmacist 36:2, pages 68-82.
Crossref
Crossref
Akram Mokhtari, Olivia Yip, Judith Alain & Simon Berthelot. (2021) Prophylactic Administration of Diphenhydramine to Reduce Neuroleptic Side Effects in the Acute Care Setting: A Systematic Review and Meta-Analysis. The Journal of Emergency Medicine 60:2, pages 165-174.
Crossref
Crossref
Joseph O. Fadare, Abimbola Margaret Obimakinde, Felix O. Aina, Ebisola J. Araromi, Theophilus Adekunle Adegbuyi, Oluwatoba E. Osasona & Tosin A. Agbesanwa. (2021) Anti-Cholinergic Drug Burden Among Ambulatory Elderly Patients in a Nigerian Tertiary Healthcare Facility. Frontiers in Pharmacology 12.
Crossref
Crossref
Marta Lavrador, M. Margarida Castel-Branco, Ana C. Cabral, Manuel T. Veríssimo, Isabel V. Figueiredo & Fernando Fernandez-Llimos. (2021) Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes. Pharmacological Research 163, pages 105306.
Crossref
Crossref
Jonas Reinold, Wiebke Schäfer, Lara Christianson, Francesco Barone-Adesi, Oliver Riedel & Federica Edith Pisa. (2020) Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal. Drugs & Aging 37:12, pages 885-897.
Crossref
Crossref
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2020) Consistency between anticholinergic burden scales in patients with Sjögren's syndrome. Revista Colombiana de Reumatología 27, pages 50-57.
Crossref
Crossref
Mehmet Ilkin Naharci & Ilker Tasci. (2020) Frailty status and increased risk for falls: The role of anticholinergic burden. Archives of Gerontology and Geriatrics 90, pages 104136.
Crossref
Crossref
Maria Stella T. Giron & Nelia P. Cortes-Maramba. (2020) Appropriateness of Medication Prescribing in Hospitalized Older Adults in a Tertiary Teaching Hospital in the Philippines: A Cross-Sectional Study. Drugs - Real World Outcomes 7:3, pages 213-219.
Crossref
Crossref
Ariël M. Vondeling, Wilma Knol, Toine C.G. Egberts & Arjen J.C. Slooter. (2020) Anticholinergic drug exposure at intensive care unit admission affects the occurrence of delirium. A prospective cohort study. European Journal of Internal Medicine 78, pages 121-126.
Crossref
Crossref
Sophia D Lin, Jane E Butler, Claire L Boswell-Ruys, Phu D Hoang, Tom Jarvis, Simon C Gandevia & Euan J McCaughey. (2020) The effect of abdominal functional electrical stimulation on bowel function in multiple sclerosis: a cohort study. Multiple Sclerosis Journal - Experimental, Translational and Clinical 6:3, pages 205521732094153.
Crossref
Crossref
Anika Mueller, Claudia D. Spies, Rahel Eckardt, Bjoern Weiss, Anne Pohrt, Klaus-Dieter Wernecke & Maren Schmidt. (2020) Anticholinergic burden of long-term medication is an independent risk factor for the development of postoperative delirium: A clinical trial. Journal of Clinical Anesthesia 61, pages 109632.
Crossref
Crossref
Elpidio Attoh-Mensah, Gilles Loggia, Pascale Schumann-Bard, Rémy Morello, Pablo Descatoire, Christian Marcelli & Chantal Chavoix. (2020) Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young–Old and Old–Old Adults. Drugs & Aging 37:4, pages 301-310.
Crossref
Crossref
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2019) Potentially inappropriate prescriptions of anticholinergic medications in patients with closed-angle glaucoma. International Ophthalmology 40:4, pages 803-809.
Crossref
Crossref
Luis Fernando Valladales-Restrepo, Milton Paredes-Mendoza & Jorge Enrique Machado-Alba. (2020) Potentially Inappropriate Prescriptions for Anticholinergic Medications for Patients with Constipation. Digestive Diseases 38:6, pages 500-506.
Crossref
Crossref
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2019) Potentially inappropriate anticholinergic drug prescriptions for patients with Sjögren's syndrome. Journal of Translational Autoimmunity 2, pages 100007.
Crossref
Crossref
Tom Marcelissen, Tina Rashid, Tiago Antunes Lopes, Nicolas Barry Delongchamps, Bogdan Geavlete, Malte Rieken, Jean-Nicolas Cornu & Mohammad Sajjad Rahnama'i. (2019) Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?. European Urology Focus 5:6, pages 1112-1119.
Crossref
Crossref
Brandon T. Suehs, Eleanor O. Caplan, Jennifer Hayden, Daniel B. Ng & Rainelle R. Gaddy. (2019) The Relationship Between Anticholinergic Exposure and Falls, Fractures, and Mortality in Patients with Overactive Bladder. Drugs & Aging 36:10, pages 957-967.
Crossref
Crossref
Carol A. C. Coupland, Trevor Hill, Tom Dening, Richard Morriss, Michael Moore & Julia Hippisley-Cox. (2019) Anticholinergic Drug Exposure and the Risk of Dementia. JAMA Internal Medicine 179:8, pages 1084.
Crossref
Crossref
Ismail O. Ishola, Mmesomachukwu O. Osele, Micah C. Chijioke & Olufunmilayo O. Adeyemi. (2019) Isorhamnetin enhanced cortico-hippocampal learning and memory capability in mice with scopolamine-induced amnesia: Role of antioxidant defense, cholinergic and BDNF signaling. Brain Research 1712, pages 188-196.
Crossref
Crossref
C. Ricardo Ramirez, M.L. Álvarez Gómez, C.A. Agudelo Vélez, S. Zuluaga Penagos, R.A. Consuegra Peña, K. Uribe Hernández, I.C. Mejía Gil, E.M. Cano Londoño, M. Elorza Parra & J.G. Franco Vásquez. (2019) Clinical characteristics, prevalence, and factors related to delirium in children of 5 to 14 years of age admitted to intensive care. Medicina Intensiva (English Edition) 43:3, pages 147-155.
Crossref
Crossref
C. Ricardo Ramirez, M.L. Álvarez Gómez, C.A. Agudelo Vélez, S. Zuluaga Penagos, R.A. Consuegra Peña, K. Uribe Hernández, I.C. Mejía Gil, E.M. Cano Londoño, M. Elorza Parra & J.G. Franco Vásquez. (2019) Características clínicas, prevalencia y factores asociados al delirium en niños de 5 a 14 años de edad ingresados en cuidados intensivos. Medicina Intensiva 43:3, pages 147-155.
Crossref
Crossref
Jovan JavoracM.M., Gorana JanjićG.G., Dejan ŽivanovićB.B., Tijana JavoracM.M. & Ana MarkovićR.R.. (2019) The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders. Hospital Pharmacology - International Multidisciplinary Journal 6:1, pages 765-773.
Crossref
Crossref
David N. Neubauer. 2019. Handbook of Sleep Research. Handbook of Sleep Research
639
648
.
Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Fernando Caravaggio, Philip Gerretsen, Araba Chintoh, Gary J. Remington, Valerie H. Taylor, Daniel J. Müeller, Ariel Graff-Guerrero & Margaret K. Hahn. (2018) Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia. Frontiers in Psychiatry 9.
Crossref
Crossref
Abdelkrim Ziad, Romain Olekhnovitch, Fabrice Ruiz, Claudine Berr, Bernard Bégaud, Marcel Goldberg, Marie Zins & Thibault Mura. (2018) Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort. Journal of Neurology, Neurosurgery & Psychiatry 89:10, pages 1107-1115.
Crossref
Crossref
Daniel Sevilla-Sánchez, Núria Molist-Brunet, Javier González-Bueno, Núria Solà-Bonada, Joan Espaulella-Panicot & Carles Codina-Jané. (2018) Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission. Geriatrics & Gerontology International 18:8, pages 1159-1165.
Crossref
Crossref
Avital Hershkovitz, Corina Angel, Shai Brill & Ran Nissan. (2018) The Association between Anticholinergic Drug Use and Rehabilitation Outcome in Post-Acute Hip Fractured Patients: A Retrospective Cohort Study. Drugs & Aging 35:4, pages 333-341.
Crossref
Crossref
Harald Hampel, Marsel M. Mesulam, A. Claudio Cuello, Ara S. Khachaturian, Martin R. Farlow, Peter J. Snyder, Ezio Giacobini & Zaven S. Khachaturian. (2017) WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. Alzheimer's & Dementia.
Crossref
Crossref
Marie Herr, Nicolas Sirven, Hélène Grondin, Sylvain Pichetti & Catherine Sermet. (2017) Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. European Journal of Clinical Pharmacology 73:9, pages 1165-1172.
Crossref
Crossref
Floor Willeboordse, François G Schellevis, Sek Hung Chau, Jacqueline G Hugtenburg & Petra J M Elders. (2017) The effectiveness of optimised clinical medication reviews for geriatric patients: Opti-Med a cluster randomised controlled trial. Family Practice 34:4, pages 437-445.
Crossref
Crossref
José N. Nobrega, Roger J. Raymond & Bruce G. Pollock. (2017) An improved, high-efficiency assay for assessing serum anticholinergic activity using cultured cells stably expressing M1 receptors. Journal of Pharmacological and Toxicological Methods 86, pages 28-33.
Crossref
Crossref
Marie Herr, Helene Grondin, Stéphane Sanchez, Didier Armaingaud, Caroline Blochet, Antoine Vial, Philippe Denormandie & Joël Ankri. (2017) Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France. European Journal of Clinical Pharmacology 73:5, pages 601-608.
Crossref
Crossref
Preshanta Naicker, Shailendra Anoopkumar-Dukie, Gary D. Grant & Justin J. Kavanagh. (2017) Anticholinergic activity in the nervous system: Consequences for visuomotor function. Physiology & Behavior 170, pages 6-11.
Crossref
Crossref
Milton Luiz Gorzoni & Renato Moraes Alves Fabbri. (2017) Applicability of Anticholinergic Risk Scale in hospitalized elderly persons. Revista Brasileira de Geriatria e Gerontologia 20:1, pages 123-128.
Crossref
Crossref
Joanne M Sloots, Christopher A Barton, Julie Buckman, Katherine L Bassett, Job van der Palen, Peter A Frith & Tanja W Effing. (2017) The predictive value of an adjusted COPD assessment test score on the risk of respiratory-related hospitalizations in severe COPD patients. Chronic Respiratory Disease 14:1, pages 72-84.
Crossref
Crossref
Santiago Perez-Lloret, Mar?a Cecilia Peralta & Francisco J. Barrantes. 2017. Psychiatry and Neuroscience Update - Vol. II. Psychiatry and Neuroscience Update - Vol. II
375
388
.
Máire O'Dwyer, Ian D. Maidment, Kathleen Bennett, Jure Peklar, Niamh Mulryan, Philip McCallion, Mary McCarron & Martin C. Henman. (2018) Association of anticholinergic burden with adverse effects in older people with intellectual disabilities: an observational cross-sectional study. British Journal of Psychiatry 209:6, pages 504-510.
Crossref
Crossref
Tanja Mayer, Jürgen Kopitz, Konstanze Plaschke, Johanna Weiss, Hanna M. Seidling & Walter E. Haefeli. (2016) Limitations of the Anticholinergic Activity Assay and Assay-Based Anticholinergic Drug Scales. The American Journal of Geriatric Psychiatry 24:12, pages 1182-1188.
Crossref
Crossref
P. J. Magin, S. Morgan, A. Tapley, C. McCowan, L. Parkinson, K. M. Henderson, C. Muth, M. S. Hammer, D. Pond, K. E. Mate, N. A. Spike, L. A. McArthur & M. L. van Driel. (2016) Anticholinergic medicines in an older primary care population: a cross-sectional analysis of medicines’ levels of anticholinergic activity and clinical indications. Journal of Clinical Pharmacy and Therapeutics 41:5, pages 486-492.
Crossref
Crossref
Preshanta Naicker, Shailendra Anoopkumar-Dukie, Gary D. Grant, David L. Neumann & Justin J. Kavanagh. (2016) Central cholinergic pathway involvement in the regulation of pupil diameter, blink rate and cognitive function. Neuroscience 334, pages 180-190.
Crossref
Crossref
Rajesh R. Tampi, Deena J. Tampi & Ambreen K. Ghori. (2015) Acetylcholinesterase Inhibitors for Delirium in Older Adults. American Journal of Alzheimer's Disease & Other Dementiasr 31:4, pages 305-310.
Crossref
Crossref
Mohammed Saji Salahudeen & Prasad S. Nishtala. (2016) Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research. Drugs & Aging 33:5, pages 305-313.
Crossref
Crossref
Mohammed Saji Salahudeen, Te-yuan Chyou & Prasad S. Nishtala. (2016) Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature. PLOS ONE 11:3, pages e0151084.
Crossref
Crossref
James A. G. Crispo, Allison W. Willis, Dylan P. Thibault, Yannick Fortin, Harlen D. Hays, Douglas S. McNair, Lise M. Bjerre, Dafna E. Kohen, Santiago Perez-Lloret, Donald R. Mattison & Daniel Krewski. (2016) Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease. PLOS ONE 11:3, pages e0150621.
Crossref
Crossref
Anna-Liisa Juola, Sarita Pylkkanen, Hannu Kautiainen, J. Simon Bell, Mikko P. Bjorkman, Harriet Finne-Soveri, Helena Soini & Kaisu H. Pitkälä. (2016) Burden of Potentially Harmful Medications and the Association With Quality of Life and Mortality Among Institutionalized Older People. Journal of the American Medical Directors Association 17:3, pages 276.e9-276.e14.
Crossref
Crossref
Santiago Perez-Lloret & Francisco J Barrantes. (2016) Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson's Disease 2:1.
Crossref
Crossref
Mohammed Saji Salahudeen, Prasad S. Nishtala & Stephen B. Duffull. (2016) The Influence of Patient Characteristics on Anticholinergic Events in Older People. Dementia and Geriatric Cognitive Disorders Extra 5:3, pages 530-541.
Crossref
Crossref
Ryan C. W. Hall & Sherif Soliman. 2016. Comprehensive Guide to Post-Traumatic Stress Disorders. Comprehensive Guide to Post-Traumatic Stress Disorders
1445
1462
.
Lisa G. Pont, Johannes T. H. Nielen, Andrew J. McLachlan, Danijela Gnjidic, Lewis Chan, Robert G. Cumming & Katja Taxis. (2015) Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures. British Journal of Clinical Pharmacology 80:5, pages 1169-1175.
Crossref
Crossref
Tanja Mayer, Walter E Haefeli & Hanna M Seidling. (2015) Different methods, different results—how do available methods link a patient’s anticholinergic load with adverse outcomes?. European Journal of Clinical Pharmacology 71:11, pages 1299-1314.
Crossref
Crossref
Yen Ying Lim, Paul Maruff, Rachel Schindler, Brian R. Ott, Stephen Salloway, Don C. Yoo, Richard B. Noto, Cláudia Y. Santos & Peter J. Snyder. (2015) Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease. Neurobiology of Aging 36:10, pages 2709-2715.
Crossref
Crossref
Tessa van der Maaden, Jenny T. van der Steen, Henrica C. W. de Vet, Wilco P. Achterberg, Froukje Boersma, Jos M. G. A. Schols, Jos F. J. M. van Berkel, David R. Mehr, Marcel Arcand, Andy I. M. Hoepelman, Raymond T. C. M. Koopmans & Cees M. P. M. Hertogh. (2015) Development of a practice guideline for optimal symptom relief for patients with pneumonia and dementia in nursing homes using a Delphi study. International Journal of Geriatric Psychiatry 30:5, pages 487-496.
Crossref
Crossref
Karen E. Mate, Karen P. Kerr, Dimity Pond, Evan J. Williams, John Marley, Peter Disler, Henry Brodaty & Parker J. Magin. (2015) Impact of Multiple Low-Level Anticholinergic Medications on Anticholinergic Load of Community-Dwelling Elderly With and Without Dementia. Drugs & Aging 32:2, pages 159-167.
Crossref
Crossref
Nastaran Eizadi-Mood, Shahla Akouchekian, Ahmad Yaraghi, Mehrnazsadat Hakamian, Rasool Soltani & Ali Mohammad Sabzghabaee. (2015) Memory Impairment following Acute Tricyclic Antidepressants Overdose. Depression Research and Treatment 2015, pages 1-4.
Crossref
Crossref
Ryan C. W. Hall & Sherif Soliman. 2015. Comprehensive Guide to Post-Traumatic Stress Disorder. Comprehensive Guide to Post-Traumatic Stress Disorder
1
15
.
Floor Willeboordse, Jacqueline G Hugtenburg, Liset van Dijk, Judith E Bosmans, Oscar J de Vries, François G Schellevis & Petra J M Elders. (2014) Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial. BMC Geriatrics 14:1.
Crossref
Crossref
V. W. Nitti, C. R. Chapple, C. Walters, M. B. Blauwet, S. Herschorn, I. Milsom, S. Auerbach & P. Radziszewski. (2014)
Safety and tolerability of the β
3
‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial
. International Journal of Clinical Practice 68:8, pages 972-985.
Crossref
Crossref
Carlos H. Rojas-Fernandez, Tejal Patel & Linda Lee. (2014) An Interdisciplinary Memory Clinic. Annals of Pharmacotherapy 48:6, pages 785-795.
Crossref
Crossref
Mary P. Murphy, Helen Carmine & Stephanie Kolakowsky-Hayner. (2014) Modifiable and Nonmodifiable Risk Factors for Falls After Traumatic Brain Injury: An Exploratory Investigation With Implications for Medication Use. Rehabilitation Nursing 39:3, pages 113-122.
Crossref
Crossref
Rachel Dispennette, David Elliott, Lisa Nguyen & Rebecca Richmond. (2014) Drug Burden Index Score and Anticholinergic Risk Scale as Predictors of Readmission to the Hospital. The Consultant Pharmacist 29:3, pages 158-168.
Crossref
Crossref
Mohammed Saji Salahudeen, Stephen B. Duffull & Prasad S. Nishtala. (2014) Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review. Drugs & Aging 31:3, pages 185-192.
Crossref
Crossref
Aibek E. Mirrakhimov, Carey L. Brewbaker, Andrew D. Krystal & Madan M. Kwatra. (2013) Obstructive sleep apnea and delirium: exploring possible mechanisms. Sleep and Breathing 18:1, pages 19-29.
Crossref
Crossref
Hege Kersten & Torgeir Bruun Wyller. (2014) Anticholinergic Drug Burden in Older People's Brain - How well is it Measured?. Basic & Clinical Pharmacology & Toxicology 114:2, pages 151-159.
Crossref
Crossref
Peter Neu. (2013) Update zum Vorgehen bei Delir, Manie und Entzug oder Intoxikation von GHB. InFo Neurologie & Psychiatrie 15:9, pages 49-54.
Crossref
Crossref
Aibek E. Mirrakhimov, Timothy Yen & Madan M. Kwatra. (2013) Delirium after cardiac surgery: Have we overlooked obstructive sleep apnea?. Medical Hypotheses 81:1, pages 15-20.
Crossref
Crossref
Philip Gerretsen & Bruce G Pollock. (2013) Cognitive risks of anticholinergics in the elderly. Aging Health 9:2, pages 159-166.
Crossref
Crossref
Joanne Bowes, Andrew J. Brown, Jacques Hamon, Wolfgang Jarolimek, Arun Sridhar, Gareth Waldron & Steven Whitebread. (2012) Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nature Reviews Drug Discovery 11:12, pages 909-922.
Crossref
Crossref
M. Wehling. (2012) Medikation im AlterMedication in the elderly. Der Internist 53:10, pages 1240-1247.
Crossref
Crossref
Jonathan E. Sevransky, O. Joseph Bienvenu, Karin J. Neufeld & Dale M. Needham. (2012) Treatment of four psychiatric emergencies in the intensive care unit. Critical Care Medicine 40:9, pages 2662-2670.
Crossref
Crossref
Sahar Karimi, Sheetal P. Dharia, Deanna S. Flora & Patricia W. Slattum. (2012) Anticholinergic Burden: Clinical Implications for Seniors and Strategies for Clinicians. The Consultant Pharmacist 27:8, pages 564-582.
Crossref
Crossref
Cathérine C.S. Delnooz & Bart P.C. van de Warrenburg. (2012) Current and future medical treatment in primary dystonia. Therapeutic Advances in Neurological Disorders 5:4, pages 221-240.
Crossref
Crossref
Gunhild Nyborg, Jørund Straand & Mette Brekke. (2012) Inappropriate prescribing for the elderly—a modern epidemic?. European Journal of Clinical Pharmacology 68:7, pages 1085-1094.
Crossref
Crossref
Adrian S. Wagg. (2012) Antimuscarinic Treatment in Overactive Bladder. Drugs & Aging 29:7, pages 539-548.
Crossref
Crossref
Qi Wu, Ling Chen, Yifan Zheng, Caixia Zhang, Linhuan Huang, Wenyuan Guo, Yingying Fang, Hongyan Zhou, Yanmei Liu, Jie Chen, Hao Qian, Wenbiao Xian, Jinsheng Zeng, Jinru Li, Zhuolin Liu & Zhong Pei. (2012) Cognitive impairment is common in Parkinson’s disease without dementia in the early and middle stages in a Han Chinese cohort. Parkinsonism & Related Disorders 18:2, pages 161-165.
Crossref
Crossref
Ulf Guenther & Finn M. Radtke. (2011) Delirium in the postanaesthesia period. Current Opinion in Anaesthesiology 24:6, pages 670-675.
Crossref
Crossref